Barclays PLC Edwards Lifesciences Corp Transaction History

Barclays PLC

$327 Billion
Q2 2024

A detailed history of Barclays PLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Barclays PLC holds 1,094,112 shares of EW stock, worth $71.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,094,112

Previous 1,316,512 16.89%

Holding current value

$71.6 Million

Previous $126 Million 19.67%

% of portfolio

0.03%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $18.7 Million - $21 Million	-222,400 Reduced 16.89%	1,094,112 $101 Million
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $1.34 Million - $1.77 Million	18,523 Added 1.43%	1,316,512 $126 Million
Q4 2023 Feb 15, 2024	BUY	$61.71 - $77.76 $11.1 Million - $13.9 Million	179,398 Added 16.04%	1,297,989 $99 Million
Q3 2023 Nov 07, 2023	SELL	$69.28 - $93.38 $5.64 Million - $7.61 Million	-81,462 Reduced 6.79%	1,118,591 $77.5 Million
Q2 2023 Aug 03, 2023	BUY	$81.41 - $94.33 $56.4 Million - $65.4 Million	693,374 Added 136.85%	1,200,053 $113 Million
Q1 2023 May 04, 2023	SELL	$74.26 - $84.51 $31.1 Million - $35.4 Million	-419,061 Reduced 45.27%	506,679 $41.9 Million
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $8.36 Million - $10.7 Million	122,365 Added 15.23%	925,740 $69.1 Million
Q3 2022 Nov 03, 2022	BUY	$82.37 - $107.29 $12 Million - $15.6 Million	145,855 Added 22.18%	803,375 $66.4 Million
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $31.9 Million - $47.2 Million	-368,352 Reduced 35.91%	657,520 $62.5 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $93.3 Million - $117 Million	-915,514 Reduced 47.16%	1,025,872 $121 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $59.6 Million - $73.2 Million	560,331 Added 40.57%	1,941,386 $252 Million
Q3 2021 Nov 09, 2021	BUY	$102.91 - $122.75 $44.9 Million - $53.5 Million	436,022 Added 46.14%	1,381,055 $156 Million
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $18.1 Million - $22.7 Million	216,339 Added 29.69%	945,033 $97.9 Million
Q1 2021 May 13, 2021	SELL	$78.68 - $90.67 $9.42 Million - $10.9 Million	-119,674 Reduced 14.11%	728,694 $60.9 Million
Q4 2020 Feb 11, 2021	BUY	$71.69 - $91.23 $2.43 Million - $3.1 Million	33,927 Added 4.17%	848,368 $77.4 Million
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $21 Million - $27.3 Million	312,313 Added 62.2%	814,441 $65 Million
Q2 2020 Aug 12, 2020	BUY	$57.54 - $76.95 $11.7 Million - $15.7 Million	203,506 Added 68.15%	502,128 $34.7 Million
Q1 2020 May 13, 2020	SELL	$52.41 - $81.0 $2.32 Million - $3.59 Million	-44,291 Reduced 12.92%	298,622 $56.3 Million
Q4 2019 Feb 10, 2020	SELL	$71.7 - $82.09 $11.2 Million - $12.8 Million	-156,308 Reduced 31.31%	342,913 $80 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $19.1 Million - $23.4 Million	-310,027 Reduced 38.31%	499,221 $110 Million
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $16.1 Million - $18.6 Million	289,463 Added 55.69%	809,248 $149 Million
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $4.02 Million - $5.37 Million	83,839 Added 19.23%	519,785 $99.5 Million
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $5.82 Million - $7.14 Million	125,329 Added 40.35%	435,946 $66.8 Million
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $3.91 Million - $4.97 Million	85,667 Added 38.08%	310,617 $54.1 Million
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $3.38 Million - $4.08 Million	-79,555 Reduced 26.13%	224,950 $32.7 Million
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $326,081 - $416,041	8,768 Added 2.96%	304,505 $42.5 Million
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $5.39 Million - $6.28 Million	159,554 Added 117.16%	295,737 $33.3 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $4.94 Million - $5.29 Million	136,183	136,183 $14.9 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account